Current Report Filing (8-k)
18 Januar 2013 - 10:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): January 18, 2013 (January 17, 2013)
CardioGenics Holdings Inc.
(Exact Name of Registrant as Specified in
its Charter)
|
Nevada
|
000-28761
|
88-0380546
|
|
|
|
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification)
|
6295 Northam Drive, Unit 8, Mississauga,
Ontario, L4V 1W8
(Address of Principal Executive Offices)(Zip
Code)
Registrant’s telephone number, including
area code: 905.673.8501
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
|
|
o
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE OF CONTENTS
|
|
|
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
|
|
|
|
SIGNATURE
|
|
|
Item 5.03 – Amendments to Articles
of Incorporation or Bylaws; Change in Fiscal Year
On
January 17, 2013, CardioGenics Holdings Inc., a Nevada corporation (the “
Company
”), filed a Certificate of
Amendment to the Company’s
Articles of Incorporation (the “
Certificate of Amendment
”) to (i)
increase the number of shares of common stock authorized for issuance from 65,000,000 to 150,000,000 and (ii) deauthorize the
Company’s Class B common stock. The Certificate of Amendment became effective upon filing. A copy of the Certificate of
Amendment is filed herewith as
Exhibit 3.1 and incorporated herein by reference.
The foregoing description of the
Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of such
document filed as Exhibits 3.1 hereto.
Item 9.01 Financial Statements and Exhibits
Exhibits
|
|
3.1
|
Certificate of Amendment to Articles of Incorporation
(Nevada) filed January 17, 2013.
|
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
CARDIOGENICS HOLDINGS INC.
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Yahia Gawad
|
|
|
|
Name:
|
Yahia Gawad
|
|
|
|
Title:
|
Chief Executive Officer
|
Dated: January 18, 2013
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
